JP Morgan Knock-Out REGN/ DE000JJ6V8M3 /
2024-09-24 9:20:19 AM | Chg.+0.02 | Bid10:30:30 AM | Ask10:30:30 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
5.22EUR | +0.38% | 5.22 Bid Size: 5,000 |
5.30 Ask Size: 5,000 |
Regeneron Pharmaceut... | 514.5797 - | 2078-12-31 | Call |
Master data
Issuer: | J.P. Morgan Securities Ltd. |
---|---|
WKN: | JJ6V8M |
Currency: | EUR |
Underlying: | Regeneron Pharmaceuticals Inc |
Type: | Knock-out |
Option type: | Call |
Strike price: | 514.5797 - |
Maturity: | Endless |
Issue date: | 2021-03-03 |
Last trading day: | 2078-12-31 |
Ratio: | 100:1 |
Exercise type: | American |
Quanto: | No |
Gearing: | 1.85 |
Knock-out: | 514.5797 |
Knock-out violated on: | - |
Distance to knock-out: | 457.43 |
Distance to knock-out %: | 47.06% |
Distance to strike price: | 457.43 |
Distance to strike price %: | 47.06% |
Calculated values
Fair value: | - |
---|---|
Implied volatility: | - |
Historic volatility: | - |
Parity: | - |
Time value: | - |
Break-even: | - |
Moneyness: | - |
Premium: | 0.06 |
Premium p.a.: | 0.00 |
Spread abs.: | 0.08 |
Spread %: | 1.53% |
Delta: | - |
Theta: | - |
Omega: | - |
Rho: | - |
Quote data
Open: | 5.22 |
---|---|
High: | 5.22 |
Low: | - |
Market phase: | - |
All quotes in EUR
Performance
1 Week | -8.58% | ||
---|---|---|---|
1 Month | -15.53% | ||
3 Months | -0.95% | ||
YTD | +43.80% | ||
1 Year | +51.30% | ||
3 Years | +155.88% | ||
5 Years | - | ||
10 Years | - |
1W High / 1W Low: | 5.79 | 5.20 |
---|---|---|
1M High / 1M Low: | 6.22 | 5.20 |
6M High / 6M Low: | 6.23 | 3.64 |
High (YTD): | 2024-08-19 | 6.23 |
Low (YTD): | 2024-04-26 | 3.64 |
52W High: | 2024-08-19 | 6.23 |
52W Low: | 2023-10-30 | 2.89 |
Avg. price 1W: | 5.60 | |
Avg. volume 1W: | 0.00 | |
Avg. price 1M: | 5.86 | |
Avg. volume 1M: | 0.00 | |
Avg. price 6M: | 4.98 | |
Avg. volume 6M: | .47 | |
Avg. price 1Y: | 4.37 | |
Avg. volume 1Y: | .24 | |
Volatility 1M: | 41.69% | |
Volatility 6M: | 37.42% | |
Volatility 1Y: | 40.12% | |
Volatility 3Y: | 76.89% |